Leigh Baldwin & CO. LLC bought a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 5,407 shares of the company’s stock, valued at approximately $695,000.
A number of other hedge funds also recently made changes to their positions in MKGAF. Madison Wealth Partners Inc purchased a new position in Merck KGaA during the 2nd quarter valued at approximately $1,031,000. Keating Financial Advisory Services Inc. purchased a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $592,000. Tocqueville Asset Management L.P. purchased a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $57,546,000. August Group Capital Ltd bought a new position in shares of Merck KGaA during the 2nd quarter valued at approximately $390,000. Finally, Great Lakes Advisors LLC bought a new position in shares of Merck KGaA during the 2nd quarter valued at approximately $183,444,000. 0.10% of the stock is currently owned by hedge funds and other institutional investors.
Merck KGaA Stock Performance
MKGAF stock opened at $163.21 on Monday. The firm has a fifty day moving average price of $162.62 and a 200 day moving average price of $148.44. Merck KGaA has a fifty-two week low of $116.68 and a fifty-two week high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm has a market cap of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
